Pfm Health Sciences, LP Biomarin Pharmaceutical Inc Call Options Transaction History

Pfm Health Sciences, LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$85.07 - $94.48 $18.1 Million - $20.1 Million	213,100 New	213,100 $18.9 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $5.1 Million - $6.84 Million	63,000 Added 35.0%	243,000 $25.1 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $14.8 Million - $17.4 Million	180,000 New	180,000 $15.3 Million
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $27.8 Million - $33.7 Million	-371,700 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $6.21 Million - $7.71 Million	85,500 Added 29.87%	371,700 $32.6 Million
Q3 2020 Nov 16, 2020	BUY	$71.87 - $131.03 $20.6 Million - $37.5 Million	286,200 New	286,200 $21.8 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.